Antifungal drug shortage in India amid an increase in invasive fungal functions during the coronavirus disease 2019 (COVID-19) pandemic.
作者信息
Arun Ashitha B, Hasan Mohammad Mehedi, Rackimuthu Sudhan, Ullah Irfan, Mir Tanveer, Saha Anwesha
机构信息
St Joseph's College, Bangalore, India.
Department of Biochemistry and Molecular Biology, Faculty of Life Science, Mawlana Bhashani Science and Technology University, Tangail, Bangladesh.
出版信息
Infect Control Hosp Epidemiol. 2022 Dec;43(12):1965-1966. doi: 10.1017/ice.2021.426. Epub 2021 Sep 23.
Abstract
摘要
相似文献
1
Antifungal drug shortage in India amid an increase in invasive fungal functions during the coronavirus disease 2019 (COVID-19) pandemic.在2019年冠状病毒病（COVID-19）大流行期间，印度出现侵袭性真菌感染增加的同时，抗真菌药物短缺。
Infect Control Hosp Epidemiol. 2022 Dec;43(12):1965-1966. doi: 10.1017/ice.2021.426. Epub 2021 Sep 23.
2
Multicenter Epidemiologic Study of Coronavirus Disease-Associated Mucormycosis, India.印度冠状病毒疾病相关毛霉菌病的多中心流行病学研究。
Emerg Infect Dis. 2021 Sep;27(9):2349-2359. doi: 10.3201/eid2709.210934. Epub 2021 Jun 4.
3
Covid-19 and mucormycosis (Black Fungus): An epidemic within the pandemic.Covid-19 与毛霉菌病（黑真菌）：大流行中的一场疫情。
Rocz Panstw Zakl Hig. 2021;72(3):239-244. doi: 10.32394/rpzh.2021.0169.
4
The lurking scourge of multidrug resistant Candida auris in times of COVID-19 pandemic.新冠疫情期间多重耐药耳念珠菌这一潜在祸害。
J Glob Antimicrob Resist. 2020 Sep;22:175-176. doi: 10.1016/j.jgar.2020.06.003. Epub 2020 Jun 12.
5
COVID associated mucormycosis: A preliminary study from a dedicated COVID Hospital in Delhi.COVID 相关毛霉菌病：德里一家专门的 COVID 医院的初步研究。
Am J Otolaryngol. 2022 Jan-Feb;43(1):103220. doi: 10.1016/j.amjoto.2021.103220. Epub 2021 Sep 11.
6
Concern over Nipah virus cases amidst the COVID-19 pandemic in India.在印度新冠疫情期间对尼帕病毒病例的担忧。
J Med Virol. 2022 Aug;94(8):3488-3490. doi: 10.1002/jmv.27745. Epub 2022 Apr 12.
7
Recommendations for diagnosis and treatment of onychomycosis during the COVID-19 pandemic.2019冠状病毒病大流行期间甲癣的诊断和治疗建议。
Dermatol Ther. 2020 Jul;33(4):e13709. doi: 10.1111/dth.13709. Epub 2020 Jun 25.
8
Multidrug-Resistant Candida auris Infections in Critically Ill Coronavirus Disease Patients, India, April-July 2020.2020 年 4 月至 7 月，印度新冠肺炎重症患者中出现耐多药念珠菌血症感染。
Emerg Infect Dis. 2020 Nov;26(11):2694-2696. doi: 10.3201/eid2611.203504. Epub 2020 Aug 27.
9
The SARS-CoV-2/COVID-19 pandemic and challenges in stroke care in India.SARS-CoV-2/COVID-19 大流行与印度卒中医疗面临的挑战。
Ann N Y Acad Sci. 2020 Aug;1473(1):3-10. doi: 10.1111/nyas.14379. Epub 2020 May 12.
10
Challenging Times for Children With Transfusion-dependent Thalassemia Amid the COVID-19 Pandemic.新冠疫情期间，依赖输血的地中海贫血患儿面临严峻挑战。
Indian Pediatr. 2020 May 15;57(5):478. doi: 10.1007/s13312-020-1831-9. Epub 2020 Apr 11.
引用本文的文献
1
Challenges Facing Antimicrobial Stewardship Programs in the Endemic Region for Coccidioidomycosis.球孢子菌病流行地区抗菌药物管理计划面临的挑战
Open Forum Infect Dis. 2024 Jan 24;11(6):ofae041. doi: 10.1093/ofid/ofae041. eCollection 2024 Jun.
2
Baseline findings of a multicentric ambispective cohort study (2021-2022) among hospitalised mucormycosis patients in India.2021 - 2022年在印度住院毛霉菌病患者中开展的一项多中心双向队列研究的基线结果。
Mycology. 2024 Jan 17;15(1):70-84. doi: 10.1080/21501203.2023.2271928. eCollection 2024.
3
Policy responses to COVID-19: lessons for the global trade and investment regime.应对 COVID-19 的政策措施：对全球贸易和投资体制的教训。
Global Health. 2023 Sep 1;19(1):66. doi: 10.1186/s12992-023-00961-6.
4
Antifungal Drugs Shortage in India amidst Looming Increase in Invasive Fungal Infections among COVID-19 Patients: An Impending Crisis.印度抗真菌药物短缺，新冠患者侵袭性真菌感染风险渐高：一场迫在眉睫的危机。
Innov Pharm. 2022 Dec 12;13(2). doi: 10.24926/iip.v13i2.4480. eCollection 2022.
5
Does COVID-19 lockdowns have impacted on global dengue burden? A special focus to India.新冠疫情封锁措施对全球登革热负担有影响吗？特别关注印度。
BMC Public Health. 2022 Jul 22;22(1):1402. doi: 10.1186/s12889-022-13720-w.
6
Over the counter drugs and self-medication: A worldwide paranoia and a troublesome situation in India during the COVID-19 pandemic.非处方药与自我药疗：在新冠疫情期间，这是一种全球范围内的偏执观念，在印度也是一个棘手的情况。
Ann Med Surg (Lond). 2022 Jun;78:103797. doi: 10.1016/j.amsu.2022.103797. Epub 2022 May 26.
7
Rhino-Orbital Cerebral Mucormycosis in a Patient With Diabetic Ketoacidosis: A Case Report and Literature Review.一名糖尿病酮症酸中毒患者的鼻眶脑毛霉菌病：病例报告及文献综述
Front Neurol. 2022 May 4;13:815902. doi: 10.3389/fneur.2022.815902. eCollection 2022.
8
COVID-19 associated pulmonary aspergillosis (CAPA): An added potential burden on India's pre-existing fungal superinfection.2019冠状病毒病相关肺曲霉病（CAPA）：给印度原有的真菌重叠感染增添了潜在负担。
Clin Epidemiol Glob Health. 2022 Jan-Feb;13:100960. doi: 10.1016/j.cegh.2021.100960. Epub 2022 Jan 4.
9
From black to white: A roadmap to containing the rise of candidiasis amidst COVID-19 and mucormycosis in India.从黑色到白色：遏制印度新冠疫情期间念珠菌病和毛霉菌病激增的路线图。
Clin Epidemiol Glob Health. 2021 Oct-Dec;12:100917. doi: 10.1016/j.cegh.2021.100917. Epub 2021 Dec 1.
10
Tuberculosis amidst COVID-19 pandemic in India: unspoken challenges and the way forward.印度新冠疫情期间的结核病：潜在挑战与未来之路
Trop Med Health. 2021 Oct 21;49(1):84. doi: 10.1186/s41182-021-00377-1.
Zotero 插件